← Back to Search

Feasibility of Visual Field Testing With a Virtual Reality Headset

N/A
Waitlist Available
Led By Brennan Eadie, MD, PhD
Research Sponsored by Brennan Eadie
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up three weeks
Awards & highlights
No Placebo-Only Group

Summary

This study aim to determine the feasibility of using a virtual reality (VR) headset (HTC Vive) to test the visual field. The VR headset test will be compared to a conventional visual field test, using the Humphrey Field Analyzer. The investigators will include 10 healthy patients without visual field defect, 10 patients with early glaucomatous visual field defect, and 10 patients with advanced visual field defect. Each patient will perform the conventional test twice and the VR headset test 4 times, divided in 3 visits within a 2 month period. The results of the tests (sensitivity thresholds) will be compared. The investigators hypothesize that the results of the conventional and VR tests will be similar.

Eligible Conditions
  • Glaucoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~three weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and three weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Visual field differential light sensitivity threshold
Secondary study objectives
Reproducibility of sensitivity values

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Single ArmExperimental Treatment1 Intervention
Patients will perform visual field testing with the Humphrey Field Analyzer and with the Virtual Reality Headset

Find a Location

Who is running the clinical trial?

Brennan EadieLead Sponsor
1 Previous Clinical Trials
120 Total Patients Enrolled
1 Trials studying Glaucoma
120 Patients Enrolled for Glaucoma
Brennan Eadie, MD, PhDPrincipal InvestigatorNova Scotia Health Authority
1 Previous Clinical Trials
120 Total Patients Enrolled
1 Trials studying Glaucoma
120 Patients Enrolled for Glaucoma
~8 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top